期刊文献+

硝苯地平联合厄贝沙坦治疗2型糖尿病合并高血压的临床疗效与安全性分析 被引量:6

下载PDF
导出
摘要 选取2017年8月~2018年7月148例2型糖尿病合并高血压患者,随机平分为对照组予以厄贝沙坦治疗,研究组在此基础上加用硝苯地平控释片治疗。结果研究组患者血压和血糖控制率分别为90. 5%和94. 6%,对照组患者血压和血糖控制率为78. 4%和83. 8%,(P <0. 05);两组均未见严重不良反应。结论厄贝沙坦联合硝苯地平控释片治疗2型糖尿病合并高血压临床疗效良好。
作者 李倩
出处 《实用糖尿病杂志》 2019年第5期44-45,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献3

二级参考文献35

  • 1杨劲松,郭春花,杨明.新型钙通道阻滞剂硝苯地平控释片治疗高血压的疗效[J].中国老年学杂志,2014,34(11):3132-3133. 被引量:19
  • 2Persson F, Lewis J B, Lewis E J, et al. Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy [J]. Clinical Journal of the American Society of Nephrology, 2011, 6(5): 1 025-1 031.
  • 3Kitada M, Kume S, Imaizumi N, et al. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/ SIRT1-independent pathway[J]. Diabetes, 2011, 60(2): 634- 643.
  • 4Sternlicht H,Bakris GL.Management of hypertension in diabetic nephropathy:how low should we go?[J].Blood Purif,2016,41(1-3):139-143.
  • 5Sweetwyne MT,Gruenwald A,Niranjan T,et al.Notch1and Notch2in podocytes play differential roles during diabetic nephropathy development[J].Diabetes,2015,64(12):4099-4111.
  • 6Aziz KM.Correlation of urine biomarkers:microalbuminuria and spot urine protein among diabetic patients.application of spot urine protein in diabetic kidney disease,nephropathy,proteinuria estimation,diagnosing and monitoring[J].Recent Pat Endocr Metab Immune Drug Discov,2015,9(2):121-133.
  • 7Blaslov K,Bulum T,Duvnjak L.Pathophysiological factors in the development of diabetic nephropathy--new insights[J].Acta Med Croatica,2014,68(2):135-140.
  • 8Koulis C,Chow BS,McKelvey M,et al.AT2Ragonist,compound 21,is reno-protective against type 1diabetic nephropathy[J].Hypertension,2015,65(5):1073-1081.
  • 9Ruilope LM,Agarwal R,Chan JC,et al.Rationale,design,and baseline characteristics of ARTS-DN:a randomized study to assess the safety and efficacy of finerenone in patients with type2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy[J].Am J Nephrol,2014,40(6):572-581.
  • 10Zhao LS,Xu CY.Effect of prazosin on diabetic nephropathy patients with positiveα1-adrenergic receptor autoantibodies and refractory hypertension[J].Exp Ther Med,2015,9(1):177-182.

共引文献199

同被引文献58

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部